Neutrophil inhibition contributes to cardioprotection by postconditioning

Background Postconditioning (postcon) reduces infarct size, myocardial superoxide (•O2) generation, and neutrophil (PMN) accumulation. It is unknown whether inhibition of PMNs influence cardioprotection by postcon. The present study tested the following hypotheses: (1) myocardial salvage by postcon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta anaesthesiologica Scandinavica 2012-01, Vol.56 (1), p.48-56
Hauptverfasser: GRANFELDT, A., JIANG, R., WANG, N.-P., MYKYTENKO, J., ELDAIF, S., DENEVE, J., ZHAO, Z.-Q., GUYTON, R. A., TØNNESEN, E., VINTEN-JOHANSEN, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 56
container_issue 1
container_start_page 48
container_title Acta anaesthesiologica Scandinavica
container_volume 56
creator GRANFELDT, A.
JIANG, R.
WANG, N.-P.
MYKYTENKO, J.
ELDAIF, S.
DENEVE, J.
ZHAO, Z.-Q.
GUYTON, R. A.
TØNNESEN, E.
VINTEN-JOHANSEN, J.
description Background Postconditioning (postcon) reduces infarct size, myocardial superoxide (•O2) generation, and neutrophil (PMN) accumulation. It is unknown whether inhibition of PMNs influence cardioprotection by postcon. The present study tested the following hypotheses: (1) myocardial salvage by postcon is modified by inhibition of PMNs and (2) postcon directly inhibits PMN •O2 generation. Methods For hypothesis 1, a deductive approach was used to determine infarct size in vivo with and without PMNs in rats, and for hypothesis 2, blood sampled from the anterior interventricular vein (AIV) in a canine model was used. Protocol 1: anesthetized rats, subjected to 30 min of coronary artery occlusion and 3 h of reperfusion, were randomized to control (n = 13), postcon (n = 13), PMN‐depletion: (n = 9), and postcon in PMN‐depleted rats (n = 9). Protocol 2: blood was sampled at baseline, 2 h and 24 h from the AIV, draining the area at risk (AAR) in anesthetized dogs with 60 min coronary occlusion ± postcon; whole blood was analyzed for •O2 by luminol‐enhanced chemiluminescence. Results Postcon and PMN depletion reduced infarct size (42.6 ± 2.1%, P 
doi_str_mv 10.1111/j.1399-6576.2011.02577.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911933540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>911933540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5357-6f2f860bebce466df01f4620c2f81506ead1a1140b10954f997d88481b7861c53</originalsourceid><addsrcrecordid>eNqNkE9v0zAYxi0EYl3HV0C5ILgk-LVjxz5wqCYYq8Y4sGlHy3Ec5pLGnZ2I9tvPaUu5ISxZ_vP-ntePH4QywAWk8XFVAJUy56ziBcEABSasqortCzQ7FV6iGcYYcgYVOUPnMa7SkZZSvkZnhACmvKIzdH1rxyH4zaPrMtc_utoNzveZ8f0QXD0ONmaDz4wOjfOb4Adr9vV6l218HBLW7AWu_3mBXrW6i_bNcZ2j-y-f7y6_5jffr64vFze5YZRVOW9JKziubW1syXnTYmhLTrBJ18Awt7oBDVDiGrBkZStl1QhRCqgrwSH1mKP3h77JztNo46DWLhrbdbq3foxKAkhKWYkT-eGfJGCCRUllmnMkDqgJPsZgW7UJbq3DLkFqilyt1JSsmpJVU-RqH7naJunb4ytjvbbNSfgn4wS8OwI6Gt21QffGxb8cI4wSMX3s04H77Tq7-28DarH4Me2SPj_oXRzs9qTX4ZdKNiqmHm6vlBDL5TcBXC3pM83Oq0o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020843984</pqid></control><display><type>article</type><title>Neutrophil inhibition contributes to cardioprotection by postconditioning</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>GRANFELDT, A. ; JIANG, R. ; WANG, N.-P. ; MYKYTENKO, J. ; ELDAIF, S. ; DENEVE, J. ; ZHAO, Z.-Q. ; GUYTON, R. A. ; TØNNESEN, E. ; VINTEN-JOHANSEN, J.</creator><creatorcontrib>GRANFELDT, A. ; JIANG, R. ; WANG, N.-P. ; MYKYTENKO, J. ; ELDAIF, S. ; DENEVE, J. ; ZHAO, Z.-Q. ; GUYTON, R. A. ; TØNNESEN, E. ; VINTEN-JOHANSEN, J.</creatorcontrib><description>Background Postconditioning (postcon) reduces infarct size, myocardial superoxide (•O2) generation, and neutrophil (PMN) accumulation. It is unknown whether inhibition of PMNs influence cardioprotection by postcon. The present study tested the following hypotheses: (1) myocardial salvage by postcon is modified by inhibition of PMNs and (2) postcon directly inhibits PMN •O2 generation. Methods For hypothesis 1, a deductive approach was used to determine infarct size in vivo with and without PMNs in rats, and for hypothesis 2, blood sampled from the anterior interventricular vein (AIV) in a canine model was used. Protocol 1: anesthetized rats, subjected to 30 min of coronary artery occlusion and 3 h of reperfusion, were randomized to control (n = 13), postcon (n = 13), PMN‐depletion: (n = 9), and postcon in PMN‐depleted rats (n = 9). Protocol 2: blood was sampled at baseline, 2 h and 24 h from the AIV, draining the area at risk (AAR) in anesthetized dogs with 60 min coronary occlusion ± postcon; whole blood was analyzed for •O2 by luminol‐enhanced chemiluminescence. Results Postcon and PMN depletion reduced infarct size (42.6 ± 2.1%, P &lt; 0.05 vs. control, and 43.9 ± 3.0%, P &lt; 0.05 vs. control, respectively) vs. control (58.8 ± 0.9%), with no further decrease with postcon in PMN‐depleted rats (37.2 ± 2.9%, P = 0.34 vs. postcon). PMN accumulation in AAR was less in postcon (21.2 ± 0.3%, P &lt; 0.05 vs. control) and PMN‐depleted (9.4 ± 0.3%, P &lt; 0.05 vs. control) vs. control (30.5 ± 1.2%), with a further decrease in the postcon + PMN depletion group (5.4 ± 0.6%, P &lt; 0.05 vs. control). In dogs, •O2 release by PMNs increased at 2 h and 24 h of R, which was reduced to baseline levels by postcon. Conclusions These data imply PMN involvement in cardioprotection by postconditioning.</description><identifier>ISSN: 0001-5172</identifier><identifier>EISSN: 1399-6576</identifier><identifier>DOI: 10.1111/j.1399-6576.2011.02577.x</identifier><identifier>PMID: 22103673</identifier><identifier>CODEN: AANEAB</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing Ltd</publisher><subject>Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blood ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Chemiluminescence ; coronary artery ; Creatine Kinase - blood ; Data processing ; Dogs ; Heart Rate - drug effects ; Heart Rate - physiology ; Immunohistochemistry ; Ischemic Postconditioning - methods ; Leukocytes (neutrophilic) ; Luminescence ; Luminol ; Male ; Medical sciences ; Myocardial Infarction - pathology ; Myocardial Infarction - prevention &amp; control ; Myocardial Reperfusion Injury - pathology ; Myocardial Reperfusion Injury - prevention &amp; control ; Myocardium - pathology ; Necrosis ; Neutrophils - drug effects ; Occlusion ; Oxygen Consumption - drug effects ; Rats ; Rats, Sprague-Dawley ; Reperfusion ; Superoxide ; Superoxides - metabolism ; Veins</subject><ispartof>Acta anaesthesiologica Scandinavica, 2012-01, Vol.56 (1), p.48-56</ispartof><rights>2011 The Authors Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation</rights><rights>2015 INIST-CNRS</rights><rights>2011 The Authors Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5357-6f2f860bebce466df01f4620c2f81506ead1a1140b10954f997d88481b7861c53</citedby><cites>FETCH-LOGICAL-c5357-6f2f860bebce466df01f4620c2f81506ead1a1140b10954f997d88481b7861c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-6576.2011.02577.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-6576.2011.02577.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25253285$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22103673$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GRANFELDT, A.</creatorcontrib><creatorcontrib>JIANG, R.</creatorcontrib><creatorcontrib>WANG, N.-P.</creatorcontrib><creatorcontrib>MYKYTENKO, J.</creatorcontrib><creatorcontrib>ELDAIF, S.</creatorcontrib><creatorcontrib>DENEVE, J.</creatorcontrib><creatorcontrib>ZHAO, Z.-Q.</creatorcontrib><creatorcontrib>GUYTON, R. A.</creatorcontrib><creatorcontrib>TØNNESEN, E.</creatorcontrib><creatorcontrib>VINTEN-JOHANSEN, J.</creatorcontrib><title>Neutrophil inhibition contributes to cardioprotection by postconditioning</title><title>Acta anaesthesiologica Scandinavica</title><addtitle>Acta Anaesthesiol Scand</addtitle><description>Background Postconditioning (postcon) reduces infarct size, myocardial superoxide (•O2) generation, and neutrophil (PMN) accumulation. It is unknown whether inhibition of PMNs influence cardioprotection by postcon. The present study tested the following hypotheses: (1) myocardial salvage by postcon is modified by inhibition of PMNs and (2) postcon directly inhibits PMN •O2 generation. Methods For hypothesis 1, a deductive approach was used to determine infarct size in vivo with and without PMNs in rats, and for hypothesis 2, blood sampled from the anterior interventricular vein (AIV) in a canine model was used. Protocol 1: anesthetized rats, subjected to 30 min of coronary artery occlusion and 3 h of reperfusion, were randomized to control (n = 13), postcon (n = 13), PMN‐depletion: (n = 9), and postcon in PMN‐depleted rats (n = 9). Protocol 2: blood was sampled at baseline, 2 h and 24 h from the AIV, draining the area at risk (AAR) in anesthetized dogs with 60 min coronary occlusion ± postcon; whole blood was analyzed for •O2 by luminol‐enhanced chemiluminescence. Results Postcon and PMN depletion reduced infarct size (42.6 ± 2.1%, P &lt; 0.05 vs. control, and 43.9 ± 3.0%, P &lt; 0.05 vs. control, respectively) vs. control (58.8 ± 0.9%), with no further decrease with postcon in PMN‐depleted rats (37.2 ± 2.9%, P = 0.34 vs. postcon). PMN accumulation in AAR was less in postcon (21.2 ± 0.3%, P &lt; 0.05 vs. control) and PMN‐depleted (9.4 ± 0.3%, P &lt; 0.05 vs. control) vs. control (30.5 ± 1.2%), with a further decrease in the postcon + PMN depletion group (5.4 ± 0.6%, P &lt; 0.05 vs. control). In dogs, •O2 release by PMNs increased at 2 h and 24 h of R, which was reduced to baseline levels by postcon. Conclusions These data imply PMN involvement in cardioprotection by postconditioning.</description><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Chemiluminescence</subject><subject>coronary artery</subject><subject>Creatine Kinase - blood</subject><subject>Data processing</subject><subject>Dogs</subject><subject>Heart Rate - drug effects</subject><subject>Heart Rate - physiology</subject><subject>Immunohistochemistry</subject><subject>Ischemic Postconditioning - methods</subject><subject>Leukocytes (neutrophilic)</subject><subject>Luminescence</subject><subject>Luminol</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - prevention &amp; control</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardial Reperfusion Injury - prevention &amp; control</subject><subject>Myocardium - pathology</subject><subject>Necrosis</subject><subject>Neutrophils - drug effects</subject><subject>Occlusion</subject><subject>Oxygen Consumption - drug effects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion</subject><subject>Superoxide</subject><subject>Superoxides - metabolism</subject><subject>Veins</subject><issn>0001-5172</issn><issn>1399-6576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE9v0zAYxi0EYl3HV0C5ILgk-LVjxz5wqCYYq8Y4sGlHy3Ec5pLGnZ2I9tvPaUu5ISxZ_vP-ntePH4QywAWk8XFVAJUy56ziBcEABSasqortCzQ7FV6iGcYYcgYVOUPnMa7SkZZSvkZnhACmvKIzdH1rxyH4zaPrMtc_utoNzveZ8f0QXD0ONmaDz4wOjfOb4Adr9vV6l218HBLW7AWu_3mBXrW6i_bNcZ2j-y-f7y6_5jffr64vFze5YZRVOW9JKziubW1syXnTYmhLTrBJ18Awt7oBDVDiGrBkZStl1QhRCqgrwSH1mKP3h77JztNo46DWLhrbdbq3foxKAkhKWYkT-eGfJGCCRUllmnMkDqgJPsZgW7UJbq3DLkFqilyt1JSsmpJVU-RqH7naJunb4ytjvbbNSfgn4wS8OwI6Gt21QffGxb8cI4wSMX3s04H77Tq7-28DarH4Me2SPj_oXRzs9qTX4ZdKNiqmHm6vlBDL5TcBXC3pM83Oq0o</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>GRANFELDT, A.</creator><creator>JIANG, R.</creator><creator>WANG, N.-P.</creator><creator>MYKYTENKO, J.</creator><creator>ELDAIF, S.</creator><creator>DENEVE, J.</creator><creator>ZHAO, Z.-Q.</creator><creator>GUYTON, R. A.</creator><creator>TØNNESEN, E.</creator><creator>VINTEN-JOHANSEN, J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201201</creationdate><title>Neutrophil inhibition contributes to cardioprotection by postconditioning</title><author>GRANFELDT, A. ; JIANG, R. ; WANG, N.-P. ; MYKYTENKO, J. ; ELDAIF, S. ; DENEVE, J. ; ZHAO, Z.-Q. ; GUYTON, R. A. ; TØNNESEN, E. ; VINTEN-JOHANSEN, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5357-6f2f860bebce466df01f4620c2f81506ead1a1140b10954f997d88481b7861c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Chemiluminescence</topic><topic>coronary artery</topic><topic>Creatine Kinase - blood</topic><topic>Data processing</topic><topic>Dogs</topic><topic>Heart Rate - drug effects</topic><topic>Heart Rate - physiology</topic><topic>Immunohistochemistry</topic><topic>Ischemic Postconditioning - methods</topic><topic>Leukocytes (neutrophilic)</topic><topic>Luminescence</topic><topic>Luminol</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - prevention &amp; control</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardial Reperfusion Injury - prevention &amp; control</topic><topic>Myocardium - pathology</topic><topic>Necrosis</topic><topic>Neutrophils - drug effects</topic><topic>Occlusion</topic><topic>Oxygen Consumption - drug effects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion</topic><topic>Superoxide</topic><topic>Superoxides - metabolism</topic><topic>Veins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GRANFELDT, A.</creatorcontrib><creatorcontrib>JIANG, R.</creatorcontrib><creatorcontrib>WANG, N.-P.</creatorcontrib><creatorcontrib>MYKYTENKO, J.</creatorcontrib><creatorcontrib>ELDAIF, S.</creatorcontrib><creatorcontrib>DENEVE, J.</creatorcontrib><creatorcontrib>ZHAO, Z.-Q.</creatorcontrib><creatorcontrib>GUYTON, R. A.</creatorcontrib><creatorcontrib>TØNNESEN, E.</creatorcontrib><creatorcontrib>VINTEN-JOHANSEN, J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Acta anaesthesiologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GRANFELDT, A.</au><au>JIANG, R.</au><au>WANG, N.-P.</au><au>MYKYTENKO, J.</au><au>ELDAIF, S.</au><au>DENEVE, J.</au><au>ZHAO, Z.-Q.</au><au>GUYTON, R. A.</au><au>TØNNESEN, E.</au><au>VINTEN-JOHANSEN, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutrophil inhibition contributes to cardioprotection by postconditioning</atitle><jtitle>Acta anaesthesiologica Scandinavica</jtitle><addtitle>Acta Anaesthesiol Scand</addtitle><date>2012-01</date><risdate>2012</risdate><volume>56</volume><issue>1</issue><spage>48</spage><epage>56</epage><pages>48-56</pages><issn>0001-5172</issn><eissn>1399-6576</eissn><coden>AANEAB</coden><abstract>Background Postconditioning (postcon) reduces infarct size, myocardial superoxide (•O2) generation, and neutrophil (PMN) accumulation. It is unknown whether inhibition of PMNs influence cardioprotection by postcon. The present study tested the following hypotheses: (1) myocardial salvage by postcon is modified by inhibition of PMNs and (2) postcon directly inhibits PMN •O2 generation. Methods For hypothesis 1, a deductive approach was used to determine infarct size in vivo with and without PMNs in rats, and for hypothesis 2, blood sampled from the anterior interventricular vein (AIV) in a canine model was used. Protocol 1: anesthetized rats, subjected to 30 min of coronary artery occlusion and 3 h of reperfusion, were randomized to control (n = 13), postcon (n = 13), PMN‐depletion: (n = 9), and postcon in PMN‐depleted rats (n = 9). Protocol 2: blood was sampled at baseline, 2 h and 24 h from the AIV, draining the area at risk (AAR) in anesthetized dogs with 60 min coronary occlusion ± postcon; whole blood was analyzed for •O2 by luminol‐enhanced chemiluminescence. Results Postcon and PMN depletion reduced infarct size (42.6 ± 2.1%, P &lt; 0.05 vs. control, and 43.9 ± 3.0%, P &lt; 0.05 vs. control, respectively) vs. control (58.8 ± 0.9%), with no further decrease with postcon in PMN‐depleted rats (37.2 ± 2.9%, P = 0.34 vs. postcon). PMN accumulation in AAR was less in postcon (21.2 ± 0.3%, P &lt; 0.05 vs. control) and PMN‐depleted (9.4 ± 0.3%, P &lt; 0.05 vs. control) vs. control (30.5 ± 1.2%), with a further decrease in the postcon + PMN depletion group (5.4 ± 0.6%, P &lt; 0.05 vs. control). In dogs, •O2 release by PMNs increased at 2 h and 24 h of R, which was reduced to baseline levels by postcon. Conclusions These data imply PMN involvement in cardioprotection by postconditioning.</abstract><cop>Oxford</cop><pub>Blackwell Publishing Ltd</pub><pmid>22103673</pmid><doi>10.1111/j.1399-6576.2011.02577.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-5172
ispartof Acta anaesthesiologica Scandinavica, 2012-01, Vol.56 (1), p.48-56
issn 0001-5172
1399-6576
language eng
recordid cdi_proquest_miscellaneous_911933540
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Blood
Blood Pressure - drug effects
Blood Pressure - physiology
Chemiluminescence
coronary artery
Creatine Kinase - blood
Data processing
Dogs
Heart Rate - drug effects
Heart Rate - physiology
Immunohistochemistry
Ischemic Postconditioning - methods
Leukocytes (neutrophilic)
Luminescence
Luminol
Male
Medical sciences
Myocardial Infarction - pathology
Myocardial Infarction - prevention & control
Myocardial Reperfusion Injury - pathology
Myocardial Reperfusion Injury - prevention & control
Myocardium - pathology
Necrosis
Neutrophils - drug effects
Occlusion
Oxygen Consumption - drug effects
Rats
Rats, Sprague-Dawley
Reperfusion
Superoxide
Superoxides - metabolism
Veins
title Neutrophil inhibition contributes to cardioprotection by postconditioning
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A36%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutrophil%20inhibition%20contributes%20to%20cardioprotection%20by%20postconditioning&rft.jtitle=Acta%20anaesthesiologica%20Scandinavica&rft.au=GRANFELDT,%20A.&rft.date=2012-01&rft.volume=56&rft.issue=1&rft.spage=48&rft.epage=56&rft.pages=48-56&rft.issn=0001-5172&rft.eissn=1399-6576&rft.coden=AANEAB&rft_id=info:doi/10.1111/j.1399-6576.2011.02577.x&rft_dat=%3Cproquest_cross%3E911933540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020843984&rft_id=info:pmid/22103673&rfr_iscdi=true